scholarly journals Regulation of Tomato Fruit Development by Interacting MYB Proteins

Author(s):  
Rivka Barg ◽  
Erich Grotewold ◽  
Yechiam Salts

Background to the topic: Early tomato fruit development is executed via extensive cell divisions followed by cell expansion concomitantly with endoreduplication. The signals involved in activating the different modes of growth during fruit development are still inadequately understood. Addressing this developmental process, we identified SlFSM1 as a gene expressed specifically during the cell-division dependent stages of fruit development. SlFSM1 is the founder of a class of small plant specific proteins containing a divergent SANT/MYB domain (Barg et al 2005). Before initiating this project, we found that low ectopic over-expression (OEX) of SlFSM1 leads to a significant decrease in the final size of the cells in mature leaves and fruits, and the outer pericarp is substantially narrower, suggesting a role in determining cell size and shape. We also found the interacting partners of the Arabidopsis homologs of FSM1 (two, belonging to the same family), and cloned their tomato single homolog, which we named SlFSB1 (Fruit SANT/MYB–Binding1). SlFSB1 is a novel plant specific single MYB-like protein, which function was unknown. The present project aimed at elucidating the function and mode of action of these two single MYB proteins in regulating tomato fruit development. The specific objectives were: 1. Functional analysis of SlFSM1 and its interacting protein SlFSB1 in relation to fruit development. 2. Identification of the SlFSM1 and/or SlFSB1 cellular targets. The plan of work included: 1) Detailed phenotypic, histological and cellular analyses of plants ectopically expressing FSM1, and plants either ectopically over-expressing or silenced for FSB1. 2) Extensive SELEX analysis, which did not reveal any specific DNA target of SlFSM1 binding, hence the originally offered ChIP analysis was omitted. 3) Genome-wide transcriptional impact of gain- and loss- of SlFSM1 and SlFSB1 function by Affymetrix microarray analyses. This part is still in progress and therefore results are not reported, 4) Search for additional candidate partners of SlFSB1 revealed SlMYBI to be an alternative partner of FSB1, and 5) Study of the physical basis of the interaction between SlFSM1 and SlFSB1 and between FSB1 and MYBI. Major conclusions, solutions, achievements: We established that FSM1 negatively affects cell expansion, particularly of those cells with the highest potential to expand, such as the ones residing inner to the vascular bundles in the fruit pericarp. On the other hand, FSB1 which is expressed throughout fruit development acts as a positive regulator of cell expansion. It was also established that besides interacting with FSM1, FSB1 interacts also with the transcription factor MYBI, and that the formation of the FSB1-MYBI complex is competed by FSM1, which recognizes in FSB1 the same region as MYBI does. Based on these findings a model was developed explaining the role of this novel network of the three different MYB containing proteins FSM1/FSB1/MYBI in the control of tomato cell expansion, particularly during fruit development. In short, during early stages of fruit development (Phase II), the formation of the FSM1-FSB1 complex serves to restrict the expansion of the cells with the greatest expansion potential, those non-dividing cells residing in the inner mesocarp layers of the pericarp. Alternatively, during growth phase III, after transcription of FSM1 sharply declines, FSB1, possibly through complexing with the transcription factor MYBI serves as a positive regulator of the differential cell expansion which drives fruit enlargement during this phase. Additionally, a novel mechanism was revealed by which competing MYB-MYB interactions could participate in the control of gene expression. Implications, both scientific and agricultural: The demonstrated role of the FSM1/FSB1/MYBI complex in controlling differential cell growth in the developing tomato fruit highlights potential exploitations of these genes for improving fruit quality characteristics. Modulation of expression of these genes or their paralogs in other organs could serve to modify leaf and canopy architecture in various crops.

2011 ◽  
Vol 68 (2) ◽  
pp. 337-350 ◽  
Author(s):  
Katja Machemer ◽  
Oxana Shaiman ◽  
Yehiam Salts ◽  
Sara Shabtai ◽  
Irina Sobolev ◽  
...  

Botany ◽  
2018 ◽  
Vol 96 (9) ◽  
pp. 621-635 ◽  
Author(s):  
Odair José Garcia de Almeida ◽  
Luiz Antonio de Souza ◽  
Adelita Aparecida Sartori Paoli ◽  
Arthur R. Davis ◽  
J. Hugo Cota-Sánchez

The family Cactaceae exhibits an assortment of fleshy and dry fruit types with various shapes dictated by the gynoecium outline and surrounding pericarpel. Consequently, conflicting terminology exists regarding cactus fruit classification because the fruit is a complex structure in which various floral parts participate in development. We examined fruit morphogenesis in four epiphytic cacti and provided a description of developmental events from post-anthesis to fruit maturation, which unveiled new structures valuable in fruit characterisation and taxonomy of the Hylocereeae and Rhipsalideae. Succinctly, the cactus fruit is a carpellar ovary embedded in a long-shoot (pericarpel). The pericarp originates from five components: internal ovarian epidermis that delimits the fruit locule, ovary (proper), collateral vascular bundles, pericarpel (receptacular origin), and external pericarpel epidermis. In addition, cell expansion and stored mucilage, a sticky substance involved in seed dispersal, occurs during fruit development. We propose the term cactidium, a complex fruit with accessory structures of pericarpellar origin surrounding the gynoecial boundary, to describe the cactus fruit. This term is appropriate because members of the Cactaceae bear unique traits, such as areoles in the reproductive structures (pericarpel), which may produce scale-leaves, bristles, and spines.


2020 ◽  
Vol 71 (12) ◽  
pp. 3759-3759
Author(s):  
Ying Gao ◽  
Wei Wei ◽  
Zhongqi Fan ◽  
Xiaodan Zhao ◽  
Yiping Zhang ◽  
...  

2011 ◽  
Vol 107 (7) ◽  
pp. 1159-1169 ◽  
Author(s):  
Christian Chevalier ◽  
Mehdi Nafati ◽  
Elodie Mathieu-Rivet ◽  
Matthieu Bourdon ◽  
Nathalie Frangne ◽  
...  

2012 ◽  
Vol 63 (15) ◽  
pp. 5613-5621 ◽  
Author(s):  
S. A. Mohammed ◽  
S. Nishio ◽  
H. Takahashi ◽  
K. Shiratake ◽  
H. Ikeda ◽  
...  

Biomedicines ◽  
2019 ◽  
Vol 7 (1) ◽  
pp. 18 ◽  
Author(s):  
Stanley Cohan ◽  
Elisabeth Lucassen ◽  
Meghan Romba ◽  
Stefanie Linch

Daclizumab (DAC) is a humanized, monoclonal antibody that blocks CD25, a critical element of the high-affinity interleukin-2 receptor (IL-2R). DAC HYP blockade of CD25 inhibits effector T cell activation, regulatory T cell expansion and survival, and activation-induced T-cell apoptosis. Because CD25 blockade reduces IL-2 consumption by effector T cells, it increases IL-2 bioavailability allowing for greater interaction with the intermediate-affinity IL-2R, and therefore drives the expansion of CD56bright natural killer (NK) cells. Furthermore, there appears to be a direct correlation between CD56bright NK cell expansion and DAC HYP efficacy in reducing relapses and MRI evidence of disease activity in patients with RMS in phase II and phase III double-blind, placebo- and active comparator-controlled trials. Therapeutic efficacy was maintained during open-label extension studies. However, treatment was associated with an increased risk of rare adverse events, including cutaneous inflammation, autoimmune hepatitis, central nervous system Drug Reaction with Eosinophilia Systemic Symptoms (DRESS) syndrome, and autoimmune Glial Fibrillary Acidic Protein (GFAP) alpha immunoglobulin-associated encephalitis. As a result, DAC HYP was removed from clinical use in 2018. The lingering importance of DAC is that its use led to a deeper understanding of the underappreciated role of innate immunity in the potential treatment of autoimmune disease.


Sign in / Sign up

Export Citation Format

Share Document